Clinical Interpretation of DFA Alpha2

The clinical evidence base for alpha2 as an independent prognostic marker is less extensive than for alpha1.

Nevertheless, several observations are clinically relevant:

• Elevated alpha2 (>1.2–1.4): May indicate impaired long-term autonomic adaptability, with excessively correlated (rigid) long-term cardiac dynamics. This has been observed in some heart failure patients and may reflect chronic sympathetic dominance with blunted neurohumoral adaptability.

• Reduced alpha2 (<0.75): Suggests loss of long-term fractal organization, with RR interval dynamics approaching random behavior at longer scales. This may reflect disruption of the slow regulatory mechanisms that normally maintain long-range correlations.

• Dissociation between alpha1 and alpha2: Conditions where alpha1 and alpha2 differ substantially (e.g., low alpha1 with preserved or elevated alpha2) may represent specific pathophysiological states worthy of further clinical investigation, though the evidence base for interpreting such dissociation patterns remains limited.

EVIDENCE LIMITATION: The prognostic significance of alpha2 as an independent marker, separate from

alpha1, has not been as extensively validated in large prospective clinical outcome studies. Clinicians should exercise caution in assigning independent prognostic weight to alpha2 values without  corroborating clinical

context.